Alfred Health
This year, the Victorian Melanoma Service (VMS) at The Alfred has seen a significant drop in referrals. But cases of melanoma have not dropped – prompting specialists to urge all Victorians to act now before it’s too late.
Artificial intelligence (AI) could soon become a powerful tool in skin cancer assessment. The Victorian Melanoma Service is currently conducting a trial into the effectiveness of the technology.
Australians will soon have greater access to potentially lifesaving treatments for rare cancers and other diseases with the establishment of a clinical trials network led by Alfred Health and Monash University.
A drug combination that offers stage 4 melanoma patients the highest change of survival will be listed on the PBS from December 1, a move which specialists at the Victorian Melanoma Service say could buy some patients at least four more years of life.
Congratulations to Adjunct Professor John Kelly, head of the Victorian Melanoma Service, on being awarded the Member of the Order of Australia.